English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD

Wu, C.-Y., Cilic, A., Pak, O., Dartsch, R. C., Wilhelm, J., Wujak, M., et al. (2023). CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 207(12), 1576-1590. doi:10.1164/rccm.202208-1603OC.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Wu, Cheng-Yu, Author
Cilic, Anis, Author
Pak, Oleg, Author
Dartsch, Ruth Charlotte, Author
Wilhelm, Jochen, Author
Wujak, Magdalena, Author
Lo, Kevin, Author
Brosien, Monika, Author
Zhang, Ruoyu, Author
Alkoudmani, Ibrahim, Author
Witte, Biruta, Author
Pedersen, Frauke, Author
Watz, Henrik, Author
Voswinckel, Robert, Author
Unther, Andreas G., Author
Ghofrani, Hossein A., Author
Brandes, Ralf P., Author
Schermuly, Ralph T., Author
Grimminger, Friedrich, Author
Seeger, Werner1, Author           
Sommer, Natascha, AuthorWeissmann, Norbert, AuthorHadzic, Stefan, Author more..
Affiliations:
1Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591698              

Content

show
hide
Free keywords: -
 Abstract: Rationale: Tobacco smoking and air pollution are primary causes of chronic obstructive pulmonary disease (COPD). However, only a minority of smokers develop COPD. The mechanisms underlying the defense against nitrosative/oxidative stress in nonsusceptible smokers to COPD remain largely unresolved.
Objectives: To investigate the defense mechanisms against nitrosative/oxidative stress that possibly prevent COPD development or progression.
Methods: Four cohorts were investigated: 1) sputum samples (healthy, n = 4; COPD, n = 37), 2) lung tissue samples (healthy, n = 13; smokers without COPD, n = 10; smoker1COPD, n = 17), 3) pulmonary lobectomy tissue samples (no/mild emphysema, n = 6), and 4) blood samples (healthy, n = 6; COPD, n = 18). We screened 3-nitrotyrosine (3-NT) levels, as indication of nitrosative/oxidative stress, in human samples. We established a novel in vitro model of a cigarette smoke extract (CSE)-resistant cell line and studied 3-NT formation, antioxidant capacity, and transcriptomic profiles. Results were validated in lung tissue, isolated primary cells, and an ex vivo model using adeno-associated virus-mediated gene transduction and human precision-cut lung slices.
Measurements and Main Results: 3-NT levels correlate with COPD severity of patients. In CSE-resistant cells, nitrosative/oxidative stress upon CSE treatment was attenuated, paralleled by profound upregulation of heme oxygenase-1 (HO-1). We identified carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) as a negative regulator of HO-1-mediated nitrosative/oxidative stress defense in human alveolar type 2 epithelial cells (hAEC2s). Consistently, inhibition of HO-1 activity in hAEC2s increased the susceptibility toward CSE-induced damage. Epithelium-specific CEACAM6 overexpression increased nitrosative/oxidative stress and cell death in human precision-cut lung slices on CSE treatment.
Conclusions: CEACAM6 expression determines the hAEC2 sensitivity to nitrosative/oxidative stress triggering emphysema development/progression in susceptible smokers.

Details

show
hide
Language(s):
 Dates: 2023-06-15
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 207 (12) Sequence Number: - Start / End Page: 1576 - 1590 Identifier: ISSN: 1073-449X